A Biotech Midsummer’s Madness
LifeSciVC
AUGUST 21, 2024
As the CEO of Lifordi Immunotherapeutics, an ADC company developing treatments for autoimmune and inflammatory diseases, there are three components to manufacture, multiple international CDMOs to manage, and complex supply chains to navigate. I can tell you that CDMO summer shutdowns are a real thing.
Let's personalize your content